Search Results - "Sun, Charlotte C"

A prospective validation study of sentinel lymph node mapping for high-risk endometrial cancer by Soliman, Pamela T, Westin, Shannon N, Dioun, Shayan, Sun, Charlotte C, Euscher, Elizabeth, Munsell, Mark F, Fleming, Nicole D, Levenback, Charles, Frumovitz, Michael, Ramirez, Pedro T, Lu, Karen H

“…Highlights • Sentinel lymph detection rates were 89% in high risk patients. • The sensitivity of SLN was 95% in high-risk endometrial cancer. • The FNR of SLN…”
Get full text

Impact of mutational status on survival in low-grade serous carcinoma of the ovary or peritoneum by Gershenson, David M, Sun, Charlotte C, Wong, Kwong-Kwok

“…Background: Low-grade serous carcinoma of the ovary or peritoneum is a distinct, well- recognized histologic subtype characterized by young age at diagnosis,…”
Get full text

Prospective phase II trial of levonorgestrel intrauterine device: nonsurgical approach for complex atypical hyperplasia and early-stage endometrial cancer by Westin, Shannon N., Fellman, Bryan, Sun, Charlotte C., Broaddus, Russell R., Woodall, Misty L., Pal, Navdeep, Urbauer, Diana L., Ramondetta, Lois M., Schmeler, Kathleen M., Soliman, Pamela T., Fleming, Nicole D., Burzawa, Jennifer K., Nick, Alpa M., Milbourne, Andrea M., Yuan, Ying, Lu, Karen H., Bodurka, Diane C., Coleman, Robert L., Yates, Melinda S.

“…The incidence of complex atypical hyperplasia and early-stage endometrioid endometrial cancer is increasing, in part owing to the epidemic of obesity, which is…”
Get full text

Use and Effectiveness of Neoadjuvant Chemotherapy for Treatment of Ovarian Cancer by Meyer, Larissa A, Cronin, Angel M, Sun, Charlotte C, Bixel, Kristin, Bookman, Michael A, Cristea, Mihaela C, Griggs, Jennifer J, Levenback, Charles F, Burger, Robert A, Mantia-Smaldone, Gina, Matulonis, Ursula A, Niland, Joyce C, O'Malley, David M, Wright, Alexi A

“…Purpose In 2010, a randomized clinical trial demonstrated noninferior survival for patients with advanced ovarian cancer who were treated with neoadjuvant…”
Get full text

Hormonal therapy for recurrent low-grade serous carcinoma of the ovary or peritoneum by Gershenson, David M, Sun, Charlotte C, Iyer, Revathy B, Malpica, Anais L, Kavanagh, John J, Bodurka, Diane C, Schmeler, Kathleen, Deavers, Michael

“…Abstract Objective To determine whether hormonal therapies have efficacy in patients with recurrent low-grade serous carcinoma of the ovary or peritoneum…”
Get full text

Factors impacting the time to ovarian cancer diagnosis based on classic symptom presentation in the United States by Huepenbecker, Sarah P., Sun, Charlotte C., Fu, Shuangshuang, Zhao, Hui, Primm, Kristin, Giordano, Sharon H., Meyer, Larissa A.

“…Background Patients with ovarian cancer often present with late‐stage disease and nonspecific symptoms, but little is known about factors affecting the time to…”
Get full text

Preoperative Gemcitabine-Based Chemoradiation for Patients With Resectable Adenocarcinoma of the Pancreatic Head by EVANS, Douglas B, VARADHACHARY, Gauri R, CHARNSANGAVEJ, Chusilp, LANO, Elizabeth A, HO, Linus, LENZI, Renato, ABBRUZZESE, James L, WOLFF, Robert A, CRANE, Christopher H, SUN, Charlotte C, LEE, Jeffrey E, PISTERS, Peter W. T, VAUTHEY, Jean-Nicolas, HUAMIN WANG, CLEARY, Karen R, STAERKEL, Gregg A

“…We conducted a phase II trial to assess the outcomes of patients who received preoperative gemcitabine-based chemoradiation and pancreaticoduodenectomy (PD)…”
Get full text

Borderline Resectable Pancreatic Cancer: The Importance of This Emerging Stage of Disease by Katz, Matthew H.G., MD, Pisters, Peter W.T., MD, FACS, Evans, Douglas B., MD, FACS, Sun, Charlotte C., DrPH, MPH, Lee, Jeffrey E., MD, FACS, Fleming, Jason B., MD, FACS, Vauthey, J. Nicolas, MD, FACS, Abdalla, Eddie K., MD, FACS, Crane, Christopher H., MD, Wolff, Robert A., MD, Varadhachary, Gauri R., MD, Hwang, Rosa F., MD

“…Background Patients with borderline resectable pancreatic adenocarcinoma (PA) include those with localized disease who have tumor or patient characteristics…”
Get full text

Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma by RAUT, Chandrajit P, TSENG, Jennifer F, PISTERS, Peter W. T, EVANS, Douglas B, SUN, Charlotte C, HUAMIN WANG, WOLFF, Robert A, CRANE, Christopher H, HWANG, Rosa, VAUTHEY, Jean-Nicolas, ABDALLA, Eddie K, LEE, Jeffrey E

“…To better understand the impact of a microscopically positive margin (R1) on patterns of disease recurrence and survival after pancreaticoduodenectomy (PD) for…”
Get full text

Long-Term Survival After Multidisciplinary Management of Resected Pancreatic Adenocarcinoma by Katz, Matthew H. G., Wang, Huamin, Fleming, Jason B., Sun, Charlotte C., Hwang, Rosa F., Wolff, Robert A., Varadhachary, Gauri, Abbruzzese, James L., Crane, Christopher H., Krishnan, Sunil, Vauthey, Jean-Nicolas, Abdalla, Eddie K., Lee, Jeffrey E., Pisters, Peter W. T., Evans, Douglas B.

“…Introduction Actual 5-year survival rates of 10–18% have been reported for patients with resected pancreatic adenocarcinoma (PC), but the use of multimodality…”
Get full text

A 2‐stage ovarian cancer screening strategy using the Risk of Ovarian Cancer Algorithm (ROCA) identifies early‐stage incident cancers and demonstrates high positive predictive value by Lu, Karen H., Skates, Steven, Hernandez, Mary A., Bedi, Deepak, Bevers, Therese, Leeds, Leroy, Moore, Richard, Granai, Cornelius, Harris, Steven, Newland, William, Adeyinka, Olasunkanmi, Geffen, Jeremy, Deavers, Michael T., Sun, Charlotte C., Horick, Nora, Fritsche, Herbert, Bast, Robert C.

“…BACKGROUND A 2‐stage ovarian cancer screening strategy was evaluated that incorporates change of carbohydrate antigen 125 (CA125) levels over time and age to…”
Get full text

Preoperative Gemcitabine and Cisplatin Followed by Gemcitabine-Based Chemoradiation for Resectable Adenocarcinoma of the Pancreatic Head by VARADHACHARY, Gauri R, WOLFF, Robert A, LEE, Jeffrey H, ROSS, William A, TAMM, Eric P, BHOSALE, Priya R, KRISHNAN, Sunil, DAS, Prajnan, HO, Linus, XIONG, Henry, ABBRUZZESE, James L, EVANS, Douglas B, CRANE, Christopher H, SUN, Charlotte C, LEE, Jeffrey E, PISTERS, Peter W. T, VAUTHEY, Jean-Nicolas, ABDALLA, Eddie, HUAMIN WANG, STAERKEL, Gregg A

“…We conducted a phase II trial of preoperative gemcitabine and cisplatin chemotherapy in addition to chemoradiation (Gem-Cis-XRT) and pancreaticoduodenectomy…”
Get full text

Expanding the Criteria for BRCA Mutation Testing in Breast Cancer Survivors by KWON, Janice S, GUTIERREZ-BARRERA, Angelica M, YOUNG, Diana, SUN, Charlotte C, DANIELS, Molly S, LU, Karen H, ARUN, Banu

“…Every year approximately 25% of women diagnosed with breast cancer are younger than 50 years of age, and almost 10% of them have a BRCA mutation. Not all…”
Get full text

Testing Women With Endometrial Cancer to Detect Lynch Syndrome by KWON, Janice S, SCOTT, Jenna L, BLAKE GILKS, C, DANIELS, Molly S, SUN, Charlotte C, LU, Karen H

“…Women with endometrial cancer as a result of Lynch syndrome may not be identified as such by Amsterdam II criteria. We estimated the costs and benefits of…”
Get full text

Prospective assessment of patient-reported outcomes in gynecologic cancer patients before and after pelvic exenteration by Armbruster, Shannon D., Sun, Charlotte C., Westin, Shannon N., Bodurka, Diane C., Ramondetta, Lois, Meyer, Larissa A., Soliman, Pamela T.

“…Pelvic exenteration (PE) is a surgical procedure associated with significant morbidity offered to select women with locally advanced or recurrent gynecologic…”
Get full text

Radical hysterectomy: A comparison of surgical approaches after adoption of robotic surgery in gynecologic oncology by Soliman, Pamela T, Frumovitz, Michael, Sun, Charlotte C, dos Reis, Ricardo, Schmeler, Kathleen M, Nick, Alpa M, Westin, Shannon N, Brown, Jubilee, Levenback, Charles F, Ramirez, Pedro T

“…Abstract Objective To compare intra-operative, postoperative and pathologic outcomes of three surgical approaches to radical hysterectomy and bilateral pelvic…”
Get full text

Prophylactic Surgery to Reduce the Risk of Gynecologic Cancers in the Lynch Syndrome by Schmeler, Kathleen M, Lynch, Henry T, Chen, Lee-may, Munsell, Mark F, Soliman, Pamela T, Clark, Mary Beth, Daniels, Molly S, White, Kristin G, Boyd-Rogers, Stephanie G, Conrad, Peggy G, Yang, Kathleen Y, Rubin, Mary M, Sun, Charlotte C, Slomovitz, Brian M, Gershenson, David M, Lu, Karen H

“…Women with the Lynch syndrome (hereditary nonpolyposis colorectal cancer) are at high risk for endometrial cancer and at increased risk for ovarian cancer. In…”
Get full text

Prospective Determination of Prevalence of Lynch Syndrome in Young Women With Endometrial Cancer by LU, Karen H, SCHORGE, John O, RODABAUGH, Kerry J, DANIELS, Molly S, SUN, Charlotte C, SOLIMAN, Pamela T, WHITE, Kristin G, LUTHRA, Rajyalakshmi, GERSHENSON, David M, BROADDUS, Russell R

“…Age younger than 50 years at the time of colon cancer diagnosis is often used as a screening criterion for Lynch syndrome (hereditary nonpolyposis colorectal…”
Get full text

Neoadjuvant chemotherapy for low-grade serous carcinoma of the ovary or peritoneum by Schmeler, Kathleen M, Sun, Charlotte C, Bodurka, Diane C, T. Deavers, Michael, Malpica, Anais, Coleman, Robert L, Ramirez, Pedro T, Gershenson, David M

“…Abstract Objective. To evaluate the response of women with low-grade serous carcinoma of the ovary or peritoneum to platinum-based neoadjuvant chemotherapy…”
Get full text

Survivors of gynecologic malignancies: impact of treatment on health and well-being by Westin, Shannon N., Sun, Charlotte C., Tung, Celestine S., Lacour, Robin A., Meyer, Larissa A., Urbauer, Diana L., Frumovitz, Michael M., Lu, Karen H., Bodurka, Diane C.

“…Purpose While overall survival from gynecologic malignancies has greatly improved over the last three decades, required treatments can lead to multiple health…”
Get full text